Epidemiology and treatment outcome of MDR and pre-XDR TB in international migrants at two reference centers in the North of Italy: a cross-sectional study coordinated by Stop TB Italia Onlus

被引:12
作者
Riccardi, N. [1 ,2 ]
Pontarelli, A. [3 ]
Alagna, R. [2 ,4 ]
Saderi, L. [5 ]
Ferrarese, M. [2 ,6 ]
Castellotti, P. [2 ,6 ]
Viggiani, P. [3 ]
Cirillo, D. [2 ,4 ]
Besozzi, G. [2 ]
Sotgiu, G. [5 ]
Codecasa, L. [2 ,6 ]
机构
[1] IRCCS San Raffaele Sci Inst, Clin Infect Dis, Via Stamira dAncona 20, I-20127 Milan, Italy
[2] StopTB Italia Onlus, Milan, Italy
[3] E Morelli Hosp ASST, Reference Ctr MDR TB & HIV TB, Sondalo, Italy
[4] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Emerging Bacterial Pathogens Unit, Milan, Italy
[5] Univ Sassari, Dept Med Surg & Expt Sci, Clin Epidemiol & Med Stat Unit, Sassari, Italy
[6] Villa Marelli Inst ASST Niguarda Ca Granda, Reg TB Reference Ctr & Lab, Milan, Italy
关键词
Tuberculosis; Migrants; Pre-XDR-TB; Access to care; RESISTANT TUBERCULOSIS; MIGRATION;
D O I
10.1016/j.puhe.2019.10.022
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: We evaluated the epidemiology and treatment outcomes of multi-drug-resistant (MDR) and pre-extensively-resistant (pre-XDR) tuberculosis (TB) in migrants at two TB reference centers in Italy. Study design: Patient selection criteria for the present study were as follows: age >= 18 years, international migrants (i.e., person who lives in a country other than his/her country of origin), MDR or pre-XDR-TB based on drug-susceptibility test findings, full availability of microbiological, radiological and clinical data. Non-intersecting populations between the two centers were selected. The primary outcome was the proportion of patients with a successful (i.e., cured and treatment completed) treatment outcome. Methods: A retrospective cross-sectional study was conducted, from 01/Jan/2000 to 01/Jan/2015, at the Regional TB Reference Centre of Lombardy Region, Villa Marelli Institute/ASST Niguarda Ca' Granda (Milan, Italy) and at the Reference Center for MDR-TB and HIV-TB, Eugenio Morelli Hospital ASST (Sondalo, Italy). All data were made anonymous. Qualitative and quantitative variables were collected in an ad hoc electronic database. The statistical software used for all computations was STATA version 15 (StataCorp, Texas, USA). Results: Overall, 116 MDR-TB and pre-XDR-TB cases were recorded: 82 (70.7%) MDR-TB and 34 (29.3%) pre-XDR-TB patients, respectively. The majority (53.5%) were from the World Health Organization European Region (excluding EU/EEA) and 75 (64.5%) were male. Median (interquartile range) age was 32 (26-39) years. TB/HIV coinfection was found in 12 (10.3%) patients. Pulmonary TB was diagnosed in 107/116 (92.2%) patients. Resistance to fluoroquinolones and second-line injectables was detected in 22/116 (19.0%) and 12/107 (11.2%) patients, respectively. Overall treatment success was reached in 95/116 (81.9%) cases. Conclusion: Pre-XDR-TB in migrants coming from high-endemic countries represents a matter of concern; therefore, prevention and control activities targeted to high-risk populations are needed to progress toward TB elimination. (C) 2019 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:17 / 21
页数:5
相关论文
共 18 条
  • [1] Latent tuberculous infection among foreign-born individuals applying to shelters in the metropolitan area of Milan
    Barcellini, L.
    Campisi, D.
    Castellotti, P. F.
    Cugnata, F.
    Ferrara, G.
    Ferrarese, M.
    Murgia, N.
    Repossi, A.
    Cirillo, D. M.
    Codecasa, L. R.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2018, 22 (10) : 1160 - +
  • [2] Migration and infectious diseases
    Castelli, F.
    Sulis, G.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2017, 23 (05) : 283 - 289
  • [3] Drivers of migration: why do people move?
    Castelli, Francesco
    [J]. JOURNAL OF TRAVEL MEDICINE, 2018, 25
  • [4] On linezolid efficacy and tolerability
    De Lorenzo, S.
    Centis, R.
    D'Ambrosio, L.
    Sotgiu, G.
    Migliori, G. B.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 39 (03) : 770 - 772
  • [5] European Centre for Disease Prevention and Control, 2016, MOL TYP SURV MULT RE
  • [6] Drug resistance and tuberculosis elimination in low-incidence countries
    Falzon, Dennis
    Zellweger, Jean-Pierre
    Migliori, Giovanni Battista
    Jaramillo, Ernesto
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (06) : 1408 - 1411
  • [7] Fattorini L, EUR RESP J
  • [8] Multidrug-resistant tuberculosis and migration to Europe
    Hargreaves, S.
    Lonnroth, K.
    Nellums, L. B.
    Olaru, I. D.
    Nathavitharana, R. R.
    Norredam, M.
    Friedland, J. S.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2017, 23 (03) : 141 - 146
  • [9] Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient
    Helbling, P.
    Kroeger, S.
    Haas, W.
    Brusin, S.
    Cirillo, D. M.
    Groenheit, R.
    Guthmann, J. -P.
    Soini, H.
    Hendrickx, D.
    van der Werf, M. J.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (08) : 918 - 919
  • [10] Extensively drug-resistant tuberculosis: epidemiology and management
    Matteelli, Alberto
    Roggi, Alberto
    Carvalho, Anna C. C.
    [J]. CLINICAL EPIDEMIOLOGY, 2014, 6 : 111 - 118